We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Streptozotocin‐induced diabetes in rats modifies the role D<sub>2</sub>, D<sub>3</sub> and D<sub>4</sub> dopamine receptors play in cardiac sympathetic inhibition.
- Authors
Rivera‐Mancilla, Eduardo; Altamirano‐Espinoza, Alain H.; Manrique‐Maldonado, Guadalupe; Villanueva‐Castillo, Belinda; Villalón, Carlos M.
- Abstract
Background: Diabetes mellitus is associated with abnormalities in peripheral/central catecholaminergic systems, including changes in catecholamine levels and receptor expression. Objective: Since quinpirole‐induced cardiac sympathetic inhibition is greater in diabetic than in normoglycemic rats, this study pharmacologically investigated the dopamine D2‐like receptor subtypes that mediate cardiac sympathetic inhibition in diabetic (streptozotocin [STZ]‐pretreated) pithed rats. Methods: Fifty male Wistar rats were pretreated with STZ, pithed and conditioned for spinal stimulation (C7‐T1) of the tachycardic sympathetic tone. The resulting increases in heart rate were evaluated following i.v. blocking doses of antagonists at D2, D3 and D4 receptors during a continuous i.v. infusion of quinpirole (an agonist at D2‐like receptors) or saline (vehicle). Results: With this experimental approach, the cardiac sympathetic inhibition produced by quinpirole in diabetic rats was: (i) unchanged after administration of vehicles and; (ii) abolished by the antagonists L‐741,626 (D2), SB‐277011‐A (D3) or L‐745,870 (D4). Conclusion: These findings in diabetic pithed rats imply that: (i) the cardiac sympathetic inhibition by quinpirole involves activation of D2/3/4 dopamine receptors; and (ii) there is a differential stimulation of these receptors compared to normoglycemic rats. These D2/3/4 receptor subtypes could be a novel drug target for the therapy of typical cardiac complications of diabetes.
- Subjects
DOPAMINE receptors; STREPTOZOTOCIN; RATS; LABORATORY rats; SPINAL cord; DIABETES complications
- Publication
Basic & Clinical Pharmacology & Toxicology, 2022, Vol 131, Issue 4, p262
- ISSN
1742-7835
- Publication type
Article
- DOI
10.1111/bcpt.13774